BNDES Approves R$86M for Blanver API Plant Expansion in Brazil

Brazil's BNDES approved R$86 million in financing for CYG Biotech, a Blanver Group company, to expand active pharmaceutical ingredient (API) production in Indaiatuba (SP). The project, supported by Macke Consultoria, will build a 10,000 sqm complex with three production units over 24 months. This signals continued investment in domestic pharmaceutical manufacturing, reducing import dependence.